AppLovin (NASDAQ:APP) Misses Q2 Sales Targets

AppLovin (APP) reported mixed Q2 CY2025 results, with revenue of $1.26 billion, up 16.5% year-on-year but missing analyst estimates, while GAAP EPS of $2.39 significantly exceeded expectations. Notably, the company posted a severe miss on Adjusted EBITDA at $1.02 million against analyst estimates of $992 million, indicating a 0.1% margin. However, AppLovin provided strong Q3 CY2025 guidance, with both revenue ($1.33 billion) and Adjusted EBITDA ($1.08 billion) projections surpassing analyst expectations, complemented by significant improvements in operating and free cash flow margins.

Analysis

AppLovin (APP) presented a complex financial picture in its Q2 CY2025 report, characterized by strong underlying profitability metrics but a notable top-line miss and a significant anomaly in reported Adjusted EBITDA. Revenue grew a robust 16.5% year-on-year to $1.26 billion, yet fell 1.2% short of analyst consensus. In contrast, GAAP EPS of $2.39 substantially beat estimates by 20.4%. The most striking data point is the reported Adjusted EBITDA of $1.02 million, which represents a 99.9% miss against expectations of $992 million. This figure appears inconsistent with the company's impressive operating margin expansion to 76.1% from 36.2% in the prior year and a strong free cash flow margin of 61%. The positive forward outlook provides a crucial counterpoint; Q3 guidance for both revenue ($1.33 billion) and Adjusted EBITDA ($1.08 billion) exceeded Wall Street forecasts. This strong guidance, particularly for EBITDA, suggests the reported Q2 figure may be an outlier or data error. However, investors should note the trend of decelerating growth, with the 11% YoY growth guided for Q3 and 13.3% analyst forecast for the next 12 months both trailing the company's 22.1% three-year compounded annual growth rate.

Key Decisions for Investors

• Investors must urgently seek clarity on the Q2 Adjusted EBITDA result, as the reported $1.02 million figure is a material anomaly that contradicts the firm's strong GAAP profit, operating margins, and Q3 EBITDA guidance of $1.08 billion.
• Place significant weight on the strong Q3 guidance, as the better-than-expected revenue and EBITDA forecasts may signal management's confidence and could offset concerns from the mixed Q2 results.
• Monitor for continued revenue growth deceleration, as the projected 11-13% growth rate is a marked slowdown from the historical 22.1% three-year CAGR, which could impact future valuation multiples.
• Consider the strength in profitability metrics such as the 76.1% operating margin and 61% free cash flow margin as key indicators of operational health, despite the headline revenue miss.